Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nobuko Yamamoto is active.

Publication


Featured researches published by Nobuko Yamamoto.


Nature Biotechnology | 2000

Microarray fabrication with covalent attachment of DNA using bubble jet technology.

Tadashi Okamoto; Tomohiro Suzuki; Nobuko Yamamoto

We have developed a method for fabricating DNA microarrays that uses a Bubble Jet ink jet device to eject 5′-terminal-thiolated oligonucleotides to a glass surface. The oligonucleotides are covalently attached to the glass surface by heterobifunctional crosslinkers that react with the amino group on the substrate and a thiol group on the oligonucleotide probe. Using this method, we fabricated DNA microarrays that carried 64 groups of 18-mer oligonucleotides encoding all possible three-base mutations in the mutational “hot spot” of the p53 tumor-suppressor gene. These were screened with a fluorescently labeled synthetic 18-mer oligonucleotide derived from the p53 gene, or segments of the p53 gene that had been PCR amplified from genomic DNA of two cell lines of human oral squamous cell carcinoma (SCC). This allowed us to discriminate between matched hybrids and 1 bp-mismatched hybrids.


Journal of Clinical Microbiology | 2010

Simple PCR-Based DNA Microarray System To Identify Human Pathogenic Fungi in Skin

Tomotaka Sato; Atsushi Takayanagi; Keisuke Nagao; Nobuhiro Tomatsu; Toshifumi Fukui; Masahiro Kawaguchi; Jun Kudoh; Masayuki Amagai; Nobuko Yamamoto; Nobuyoshi Shimizu

ABSTRACT Fungal diseases in immunocompromised hosts pose significant threats to their prognoses. An accurate diagnosis and identification of the fungal pathogens causing the infection are critical to determine the proper therapeutic interventions, but these are often not achieved, due to difficulties with isolation and morphological identification. In an effort to ultimately carry out the simultaneous detection of all human pathogenic microbes, we developed a simple system to identify 26 clinically important fungi by using a combination of PCR amplification and DNA microarray assay (designated PCR-DM), in which PCR-amplified DNA from the internal transcribed spacer region of the rRNA gene was hybridized to a DNA microarray fabricated with species-specific probes sets using the Bubble Jet technology. PCR-DM reliably identified all 26 reference strains; hence, we applied it to cases of onychomycosis, taking advantage of the accessibility of tissue from skin. PCR-DM detected fungal DNA and identified pathogens in 92% of 106 microscopy-confirmed onychomycosis specimens. In contrast, culture was successful for only 36 specimens (34%), 3 of which had results inconsistent with the results of PCR-DM, but sequence analysis of the isolates proved that the PCR-DM result was correct. Thus, PCR-DM provides a powerful method to identify pathogenic fungi with high sensitivity and speed directly from tissue specimens, and this concept could be applied to other fungal or nonfungal infectious human diseases in less accessible anatomical sites.


Annals of Surgical Oncology | 2007

Detection of Minimal Gastric Cancer Cells in Peritoneal Washings by Focused Microarray Analysis with Multiple Markers: Clinical Implications

K. Mori; Tomohiro Suzuki; Hiroshi Uozaki; Hayao Nakanishi; Tetsuya Ueda; Yoshihiro Matsuno; Yasuhiro Kodera; Hiromi Sakamoto; Nobuko Yamamoto; Mitsuru Sasako; Michio Kaminishi; Hiroki Sasaki

BackgroundPeritoneal cytology is an important prognostic factor of gastric cancer. However, peritoneal cytology requires great skill, which may explain its low prevalence. A reverse transcriptase–polymerase chain reaction–based assay with multiple marker genes or immunocytochemistry was assessed as an alternative method of gathering the same kind of data as cytology.MethodsPeritoneal washings from 179 patients with gastric cancer were analyzed by multiplex reverse transcriptase–polymerase chain reaction with 10 marker genes and subsequent hybridization to a customized oligo-nucleotide array. Results with this assay were either validated as a prognostic factor or confirmed by demonstrating the presence of cancer cells by immunocytochemical cytology.ResultsOnly 1 (2.2%) of 44 disease-free cases was shown to be positive by the microarray assay, whereas 13 (93%) of 14 conventional cytology–positive cases were found to be positive. This assay further detected approximately one-third of cytology-negative patients either with peritoneal recurrence (7 of 20, 35%) or with non-peritoneal recurrence (6 of 22, 27%). A high concordance between the microarray assay and immunocytochemical cytology with five antibodies against CK20, FABP1, MUC2, TFF1, and MASPIN was confirmed. The clinical outcome of the microarray assay–positive cases was poor, as was that of the cytology-positive cases.ConclusionsOur assay, though time-consuming and requiring special equipment, demonstrated a specificity and sensitivity equal to or better than cytology in our institutes. The minimal free peritoneal cancer cells detected by the microarray assay may provide the same clinical information as larger amounts of cancer cells for patients with gastric cancer. An anti-MASPIN antibody may be helpful in peritoneal cytology of gastric cancer.


Nucleosides, Nucleotides & Nucleic Acids | 1998

Interaction of Pyrylium Dye with Self-Complementary DNA Oligomer as Studied by H NMR Spectroscopy‡

Kenji Kanaori; Kayo Yokoyama; Kunihiko Tajima; Nobuko Yamamoto; Tadashi Okamoto; Keisuke Makino

Abstract Interaction of 2-methyl-4,6-bis-(4-N,N-dimethylaminophenyl) pyrylium salt (P2) with [d(CGACGTCG)]2 was investigated by H NMR spectroscopy. The aromatic signals of P2 and the oligomer were shifted to the upfield by forming the complex, and intermolecular NOEs were also observed between P2 and the terminal CpG base steps but not between P2 and the central CpG. These results indicate that P2 binds to the weakly stacking CpG steps in an intercalation manner. This paper is dedicated to the memory of late Professor Tsujiaki Hata.


Archive | 1998

Ink jet method of spotting a probe and manufacturing a probe array

Tadashi Okamoto; Nobuko Yamamoto; Tomohiro Suzuki


Archive | 1996

Method for detecting a target nucleic acid by using an interaction of two kinds of reagents

Tadashi Okamoto; Yoshinori Tomida; Nobuko Yamamoto; Masahiro Kawaguchi; Keisuke Makino; Akira Murakami


Archive | 1998

METHOD FOR SPOTTING PROBE ONTO SOLID PHASE, PROBE ARRAY AND ITS PRODUCTION, AND DETECTION OF TARGET MATERIAL USING THE SAME, AND SPECIFICATION OF STRUCTURE OF TARGET MATERIAL

Hisashi Okamoto; Tomohiro Suzuki; Nobuko Yamamoto; 伸子 山本; 尚志 岡本; 智博 鈴木


Archive | 1989

Ion permeable membrane and ion transport method by utilizing said membrane

Junji Ohyama; Harumi Iwashita; Kinya Kato; Nobuko Yamamoto; Masanori Sakuranaga; Tsunehiro Kanno; Yasuko Tomida


Archive | 1998

Method of spotting probe on solid support, probe array and method of manufacturing thereof, and method of detecting target substance and method of identifying structure of target substance using probe array

Tadashi Okamoto; Nobuko Yamamoto; Tomohiro Suzuki


Archive | 2004

Infectious etiologic agent detection probe and probe set, carrier, and genetic screening method

Nobuko Yamamoto; Masaya Ogura; Masahiro Kawaguchi; Mamoru Tsukada; Hiroto Yoshii; Tomohiro Suzuki; Mie Ishii; Toshifumi Fukui

Collaboration


Dive into the Nobuko Yamamoto's collaboration.

Researchain Logo
Decentralizing Knowledge